DHG Pharmaceutical JSC

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DHG0
VND
93,700.00
-4100 (-4.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
11,98,100.18
17,42,471.81
11,45,709.09
11,84,237.01
11,94,544.78
14,58,678.27
10,61,838.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11,98,100.18
17,42,471.81
11,45,709.09
11,84,237.01
11,94,544.78
14,58,678.27
10,61,838.69
Raw Material Cost
5,98,052.41
9,44,563.60
5,84,235.16
5,99,010.66
6,27,158.64
8,47,934.25
6,00,586.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,51,001.01
11,50,179.83
2,68,820.37
2,59,293.97
2,60,685.95
0.00
2,60,534.14
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
2,998.99
9,939.50
6,508.65
6,242.80
8,234.65
7,653.08
Selling and Distribution Expenses
2,70,807.83
5,76,056.52
3,36,451.43
3,31,269.33
2,82,095.59
3,41,877.26
3,00,353.97
Other Expenses
-25,100.10
-1,15,317.88
-27,875.99
-26,580.26
-26,692.87
-823.47
-26,818.72
Total Expenditure (Excl Depreciation)
8,68,860.24
15,20,620.12
9,20,686.59
9,30,279.99
9,09,254.23
11,89,811.50
9,00,940.87
Operating Profit (PBDIT) excl Other Income
329239.89999999997
221851.69999999998
225022.5
253957
285290.5
268866.8
160897.80000000002
Other Income
18,029.24
1,015.59
19,938.51
24,914.92
14,128.73
6,832.94
20,835.13
Operating Profit (PBDIT)
3,76,721.27
3,41,280.21
2,74,828.42
3,08,667.74
3,28,630.19
3,31,351.82
2,12,570.09
Interest
0.00
2,998.99
9,939.50
6,508.65
6,242.80
8,234.65
7,653.08
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
6,00,047.77
7,97,908.21
5,61,473.93
5,85,226.36
5,67,386.13
6,10,744.02
4,61,251.78
Depreciation
29,452.10
1,18,412.93
29,867.41
29,795.79
29,210.92
55,652.11
30,837.15
Profit Before Tax
3,47,269.18
2,19,868.30
2,35,021.52
2,72,363.30
2,93,176.47
2,67,465.06
1,74,079.86
Tax
31,591.90
35,071.17
25,377.24
35,468.43
26,936.62
59,272.84
18,065.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,05,706.96
1,84,797.13
2,02,854.95
2,29,288.02
2,57,752.65
2,08,192.21
1,50,834.28
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,05,706.96
1,84,797.13
2,02,854.95
2,29,288.02
2,57,752.65
2,08,192.21
1,50,834.28
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,05,706.96
1,84,797.13
2,02,854.95
2,29,288.02
2,57,752.65
2,08,192.21
1,50,834.28
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
44,42,942.46
41,37,265.18
39,97,690.06
37,88,045.78
43,60,994.95
40,94,755.10
44,09,547.17
Earnings per share (EPS)
2338.17
1413.4
1551.52
1753.69
1971.4
1592.34
1153.64
Diluted Earnings per share
2338.17
1413.4
1551.52
1753.69
1971.4
1592.34
1153.64
Operating Profit Margin (Excl OI)
27.48%
12.73%
19.64%
21.44%
23.88%
18.43%
15.15%
Gross Profit Margin
31.44%
19.41%
23.12%
25.52%
26.99%
22.15%
19.3%
PAT Margin
25.52%
10.61%
17.71%
19.36%
21.58%
14.27%
14.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.30% vs -5.08% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 18.60% vs 19.85% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 14.05% vs 23.11% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -100.00% vs 18.88% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of DHG Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
11,98,100.18
5,46,206.33
6,51,893.85
119.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
11,98,100.18
5,46,206.33
6,51,893.85
119.35%
Raw Material Cost
5,98,052.41
3,22,003.21
2,76,049.20
85.73%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
2,51,001.01
0.00
2,51,001.01
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
2,476.16
-2,476.16
-100.00%
Selling and Distribution Expenses
2,70,807.83
1,20,509.87
1,50,297.96
124.72%
Other Expenses
-25,100.10
-247.62
-24,852.48
-10,036.54%
Total Expenditure (Excl Depreciation)
8,68,860.24
4,42,513.08
4,26,347.16
96.35%
Operating Profit (PBDIT) excl Other Income
3,29,239.94
103,693.26
2,25,546.68
217.51%
Other Income
18,029.24
1,597.16
16,432.08
1,028.83%
Operating Profit (PBDIT)
3,76,721.27
1,31,028.38
2,45,692.89
187.51%
Interest
0.00
2,476.16
-2,476.16
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
6,00,047.77
2,24,203.12
3,75,844.65
167.64%
Depreciation
29,452.10
25,737.97
3,714.13
14.43%
Profit Before Tax
3,47,269.18
1,02,814.25
2,44,454.93
237.76%
Tax
31,591.90
20,795.66
10,796.24
51.92%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,05,706.96
73,070.36
2,32,636.60
318.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,05,706.96
73,070.36
2,32,636.60
318.37%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,05,706.96
73,070.36
2,32,636.60
318.37%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
44,42,942.46
23,78,540.77
20,64,401.69
86.79%
Earnings per share (EPS)
2,338.17
474.46
1,863.71
392.81%
Diluted Earnings per share
2,338.17
474.46
1,863.71
392.81%
Operating Profit Margin (Excl OI)
27.48%
18.98%
0.00
8.50%
Gross Profit Margin
31.44%
23.54%
0.00
7.90%
PAT Margin
25.52%
13.38%
0.00
12.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,19,810.02 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -31.24% vs 52.09% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.30% vs -5.08% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 30,570.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 65.43% vs -8.90% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 18.60% vs 19.85% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35,869.20 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 5.42% vs 33.49% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 14.05% vs 23.11% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.48%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025